title: Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
abstract: Epstein-Barr virus (EBV)-mediated lymphoid proliferations occur in patients who are immunocompromised and are reported following bone marrow or solid organ transplantation. Most post-transplant lymphoproliferative disorders (PTLD) are polymorphic in appearance; some are monomorphic and can resemble conventional malignant lymphomas. PTLD that resembles Hodgkin lymphoma has been reported infrequently. We herein report seven cases of PTLD that have large numbers of Reed-Sternberg-like (RS-like) cells and highlight differences in the phenotype of these cases that may distinguish Hodgkin-like PTLD (HL-PTLD) from true Hodgkin lymphoma/disease (HD). All patients were in the second decade of life and were 8 months to 13 years following transplant. HL-PTLD involves lymph nodes that contain a mixed population of small to intermediate-sized lymphocytes with large mononuclear and occasionally binucleate RS-like cells. The large cells of HL-PTLD are pleomorphic B cells that react strongly for CD20 and/or CD79a, express CD30, but are usually negative for CD15 and have few mitoses. They are positive for EBV early RNA (EBER) using an EBER-1 probe, as are some of the background small lymphocytes. A single case of true Hodgkin lymphoma has highly atypical RS-like cells that contain numerous mitoses, does not have CD20 or CD79a reactivity, has CD15 and CD30 staining, and the EBER-1 probe is confined to the large cells only. All patients were managed by withdrawal of immunosuppression and variably treated with either antiviral or anti-CD20 monoclonal antibody, or with chemotherapy. A unique instance of evolution from a HL-PTLD to true HD is also illustrated. In conclusion, HL-PTLD and HD appear to be two related but immunophenotypically and biologically distinct forms of lymphoproliferation in post-transplant patients and may require different protocols for their management.
authors.affiliation: Department of Pathology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 3705 5th Avenue, 15213, Pittsburgh, PA, USA. rangsx@chp.edu
authors.forename: S
authors.initials: S
authors.lastname: Ranganathan
authors.forename: S
authors.initials: S
authors.lastname: Webber
authors.forename: S
authors.initials: S
authors.lastname: Ahuja
authors.forename: R
authors.initials: R
authors.lastname: Jaffe
mesh_terms: D000293:Adolescent; D002648:Child; D003937:Diagnosis, Differential; D020031:Epstein-Barr Virus Infections / Q000150:complications; D005260:Female; D006689:Hodgkin Disease / Q000209:etiology* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000378:metabolism / Q000473:pathology*; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects*; D012367:RNA, Viral / Q000378:metabolism
chemical_list: C099537:Epstein-Barr virus encoded RNA 1; D012367:RNA, Viral